Clinical trial registry record

Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT07275359
Last registry update
April 29, 2026
Status
Not Yet Recruiting
Phase
PHASE1
Sponsor
Duke University
Enrollment
45
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Metformin · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.